Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
04/2009
04/16/2009WO2007034254A3 Amino-alkyl-amide derivatives as ccr3 receptor ligands
04/16/2009WO2003082205A3 Compounds and methods
04/16/2009US20090099264 Fluoroalkylamine Derivatives as Cathepsin Inhibtors
04/16/2009US20090099253 Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
04/16/2009US20090099204 Amide derivative, insecticide containing the same and method for application thereof as insecticide
04/16/2009US20090099186 Inhibitors of viral replication
04/16/2009US20090099147 Non-steroidal progesterone receptor modulators
04/16/2009CA2702101A1 Aryl amides useful as inhibitors of voltage-gated sodium channels
04/15/2009EP2047828A1 A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container
04/15/2009EP2046752A1 Vr1 vanilloid receptor antagonists with a iononic substructure
04/15/2009EP1945621B1 Process to prepare amino acid derivatives
04/15/2009EP1833783B1 Durable coating compositions containing novel aspartic amine compounds
04/15/2009EP1687257B1 Amino-substituted ethylamino beta2 adrenergic receptor agonists
04/15/2009CN101410368A Viral polymerase inhibitors
04/15/2009CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof
04/14/2009US7518005 Water-soluble anti-dandruff compounds and compositions thereof
04/14/2009US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
04/09/2009WO2009043784A1 Cyclopropyl aryl amide derivatives and uses thereof
04/09/2009WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
04/09/2009US20090093525 N-(1,1-dialkyl-2-arylcyclopropyl)arylcarboxamides, e.g., Chloro-N-[cis-2,2-dimethyl-3-(4-sulfamoyl-phenyl)-cyclopropyl]-2-methoxy-benzamide; nicotinic acetylcholine receptor ligands, particularly positive allosteric modulators for the alpha 7 nAChR subtype
04/09/2009US20090093463 Novel compounds of substituted and unsubtituted adamantyl amides
04/09/2009US20090093388 Novel acyl group-containing composition
04/09/2009DE4435114B4 Verwendung einer wässrigen Zusammensetzung, die kokosfettsäurediethanolamid enthält, für eine Pestizidzusammensetzung Use of an aqueous composition containing coconut fatty acid diethanolamide, a pesticidal composition
04/09/2009CA2701509A1 Additive useful for stabilizing crude oil
04/09/2009CA2699862A1 Additive useful for stabilizing fuel oils
04/09/2009CA2699625A1 Cyclopropyl aryl amide derivatives and uses thereof
04/08/2009EP2044045A2 A process for the preparation of substituted 2-acetylamino-alkoxyphenyl
04/08/2009EP2044003A1 Process for converting primary amidoalcohols to amidocarboxylic acids in high yield using water as solvent
04/08/2009CN101405260A Amine derivatives
04/08/2009CN101405258A N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475776C Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents
04/08/2009CN100475034C Use of phenethyl acrylamides, novel phenethyl acrylamides, method for producing same and composition contg. same
04/07/2009US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
04/07/2009US7514393 Preparation of functional monomers for grafting to low molecular weight polyalkenes and their use in the preparation of dispersants and lubricating oil compositions containing dispersant polyalkenes
04/07/2009CA2362833C Phenylalaninol derivatives
04/02/2009WO2009041470A1 Method for producing hydroxylated adamantane using cytochrome p450
04/02/2009WO2009040054A1 Method for the production of optically active alpha alkyl carbonyl compounds
04/02/2009WO2009039943A1 (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
04/02/2009WO2009039942A1 (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
04/02/2009CA2700028A1 (carboxylalkylenephenyl)phenyloxamides, method for the production thereof and use of same as a medicament
04/02/2009CA2700025A1 (cyclopropylphenyl)phenyloxamides, method for the production thereof, and use of same as a medicament
04/01/2009EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists
04/01/2009EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases
04/01/2009EP2041071A2 Biaryl compositions and methods for modulating a kinase cascade
04/01/2009EP2041068A1 Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
04/01/2009EP2040688A1 New cxcr2 inhibitors
04/01/2009EP1551522B1 Purification of n,n-dimethylacetamide
04/01/2009CN101397263A Method for preparing diacetyl ethylenediamine
04/01/2009CN101397262A Preparation method of N-butoxymethyl acrylamide
04/01/2009CN101397261A Regeneration method of dimethylformamide as extracting solvent for cracking carbon 5 and use thereof
04/01/2009CN101397260A Technology for recovering dimethylformamide from waste water by combination of saline extraction and rectification method
03/2009
03/31/2009US7511168 Alkylation of a hydroxy-protected 2-(amido, carboxy, or thiocarboxy)methyl-4-hydroxypent-2-enone at the 3-position, deprotecting, resolving diastereomers by crystallization; simplification; cost efficiency
03/31/2009US7511077 Aromatic derivatives of aliphatic diamines to ameliorate unwanted T-type and N-type calcium ion channel activity; stroke, pain; N-{(Z)-4-[6,6-Bis-(4-fluoro-phenyl)-hexanoylamino]-but-2-enyl}-3,4,5-trimethoxy-benzamide
03/31/2009US7511043 farnesoid X receptor; to mitigate and thereby treat hypercholesterolemia; antagonists, which block the negative feedback downregulation of cyp7a expression produced by certain cholic acids
03/31/2009CA2292549C Use of colchinol derivatives as vascular damaging agents
03/26/2009WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient
03/26/2009US20090082596 Process for the Preparation of Adamantanamines
03/26/2009US20090082464 Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
03/26/2009US20090082463 N-substituted phenylacetamide derivative and pharmaceutical composition containing the same
03/26/2009US20090082462 Deuterium-enriched armodafinil
03/26/2009US20090082459 Deuterium-enriched guanfacine
03/26/2009US20090082378 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor
03/25/2009EP2039697A1 Fluoroboron compound, aminomethylating agent for aromatic ring comprising the compound, and process for production of compound having aminomethyl-aromatic ring using the aminomethylating agent
03/25/2009EP2038248A2 Combination of ceramide and oxaliplatin for inducing cell death and uses thereof in treating cancer
03/25/2009EP1670849B1 Aspartate derivatives and process for their preparation
03/25/2009EP1641740B1 Method for producing an optically active nitro compound
03/25/2009CN101395129A Metal carboxylate salt nucleating or clarifying agent compounds and related polymer compositions and methods
03/25/2009CN101391967A Method for producing acrylic amide crystal
03/24/2009US7507859 Quaternary ammonium compound having ester and/or amide groups; cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids
03/24/2009US7507836 Benzamide modulators of metabotropic glutamate receptors
03/24/2009US7507765 Mevalonic acid derivatives; antitumor/anticancer agents
03/19/2009WO2009036206A1 Solid forms of selective androgen receptor modulators
03/19/2009WO2009035362A1 Chemical foaming agent porofor
03/19/2009WO2009034457A1 Organic compounds useful for the treatment of neurodegenerative diseases, uses and methods for the preparation thereof
03/19/2009WO2009034308A2 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
03/19/2009WO2009034258A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
03/19/2009US20090076301 Methods for producing nateglinide crystals
03/19/2009US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors
03/19/2009US20090076235 Copolymerizable methine and anthraquinone compounds and articles containing them
03/19/2009US20090076157 Deuterium-enriched senicapoc
03/19/2009US20090076156 Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
03/19/2009US20090076155 benzoic acid derivatives, used as acetyltransferase enzyme inhibitors, used in the treatment of diseases due to defects in gene regulation predominantly cancer
03/19/2009US20090076153 Deuterium-enriched tigecycline
03/19/2009US20090076152 Novel Compounds Active as Muscarinic Receptor Antagonists
03/19/2009US20090075989 Non-steroidal progesterone receptor modulators
03/19/2009US20090075952 Nitroderviatives as drugs for diseases having an inflammatory basis
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/19/2009US20090074709 Methods, devices and systems for biocidal surface activity
03/19/2009US20090074673 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
03/19/2009DE102007044296A1 New carbonyl containing chemical compounds are protein modulators useful e.g. for the polymerization of proteins with transglutaminase, in transglutaminase catalyzed process, and for the modification of proteins with transglutaminase
03/19/2009CA2709118A1 Solid forms of selective androgen receptor modulators
03/19/2009CA2698795A1 Process for the preparation of a raf kinase inhibitor and intermediates for use in the process
03/19/2009CA2692702A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
03/18/2009EP2036882A1 Zwitterionic connections and their use
03/18/2009EP2035368A1 Process for the preparation of (r)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid and of pregabalin and synthesis intermediates
03/18/2009EP1951769B1 Polymer having sulfonic acid group or sulfonic acid ester group and amide group, and toner for developing electrostatic latent image having the polymer
03/18/2009EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/18/2009CN101389616A Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 289